Balasis, M., Forinash, K., Chen, Y., Fulp, W., Coppola, D., Hamilton, A., . . . Sebti, S. (2011). Combination of farnesyltransferase and Akt inhibitors is synergistic in breast cancer cells and causes significant breast tumor regression in ErbB2 transgenic mice.
Chicago Style (17th ed.) CitationBalasis, M., K. Forinash, Y. Chen, W. Fulp, D. Coppola, A. Hamilton, J. Cheng, and S. Sebti. Combination of Farnesyltransferase and Akt Inhibitors Is Synergistic in Breast Cancer Cells and Causes Significant Breast Tumor Regression in ErbB2 Transgenic Mice. 2011.
MLA引文Balasis, M., et al. Combination of Farnesyltransferase and Akt Inhibitors Is Synergistic in Breast Cancer Cells and Causes Significant Breast Tumor Regression in ErbB2 Transgenic Mice. 2011.
警告:這些引文格式不一定是100%准確.